Literature DB >> 22476878

Artificial liver support system reduces intracranial pressure more effectively than bioartificial system: an experimental study.

Ondrej Ryska1, Tomas Pantoflicek, Eva Laszikova, Josef Prazak, Eva Koblihova, Miroslav Ryska.   

Abstract

OBJECTIVES: Extracorporeal liver support (ELS) may play a role in bridging therapy in patients with acute liver failure (ALF). The aim of this study was to compare the influence of nonbiological and biological methods on intracranial pressure (ICP) in an animal model of ALF.
METHODS: A surgical devascularization model of ALF in pigs (35-40 kg) was used. Elimination therapy started after the onset of hypoglycemia. Biochemical parameters (bilirubin, ammonia, lactate, etc.) as well as ICP and cerebral perfusion pressure (CPP) were monitored for 12 hours. Of the total 31 pigs with ALF, 14 animals were treated by fractionated plasma separation and absorption (FPSA), 10 were treated with a bioartificial liver (BAL), and 7 animals were used as a control group.
RESULTS: FPSA and BAL treatment started on average 3 hours 17 minutes and 2 hours 21 minutes, after devascularization and lasted for 5 hours 54 minutes and 5 hours 43 minutes, respectively. Ammonia levels were lower in the FPSA group, and bilirubin levels differed significantly in both the FPSA and BAL groups compared with controls. However, ICP values were reduced more effectively in pigs treated by FPSA: 19.1 vs. 27.0 mm Hg at 9 hours, 22.5 vs. 28.7 mm Hg at 11 hours, and 24.0 vs. 33.0 mm Hg at 12 hours (p<0.05).
CONCLUSIONS: The artificial liver support system FPSA reduced ICP values more effectively than the Performer O. Liver RanD BAL system. Compared with this BAL system, the nonbiological elimination method of FPSA is a simpler application with the advantage that it can be applied in a more continuous way.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22476878     DOI: 10.5301/ijao.5000099

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  3 in total

1.  Establishment of a Novel Simplified Surgical Model of Acute Liver Failure in the Cynomolgus Monkey.

Authors:  Lei Cai; Jun Weng; Lei Feng; Guolin He; Jiasheng Qin; Zhi Zhang; Yang Li; Qing Peng; Zesheng Jiang; Mingxin Pan; Yi Gao
Journal:  Biomed Res Int       Date:  2016-12-21       Impact factor: 3.411

2.  Prometheus therapy for the treatment of acute liver failure in patients after cardiac surgery.

Authors:  Ekaterina Komardina; Michael Yaroustovsky; Marina Abramyan; Marina Plyushch
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-12-20

3.  Part of plasmapheresis with plasma filtration adsorption combined with continuous hemodiafiltration in the treatment of severe acute liver failure.

Authors:  Maoqin Li; Zhidong Wang; Yining Wang; Changhong Du; Songhai Li; Zaixiang Shi; Bo Lu
Journal:  Exp Ther Med       Date:  2016-08-30       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.